Toviaz (Avera McKennan Hospital)


Welcome to the PulseAid listing for the Toviaz drug offered from Avera McKennan Hospital. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Avera McKennan Hospital
NON-PROPRIETARY NAME: fesoterodine fumarate
SUBSTANCE NAME: FESOTERODINE FUMARATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-04-01
END MARKETING DATE: 0000-00-00


Toviaz HUMAN PRESCRIPTION DRUG Details:

Item DescriptionToviaz from Avera McKennan Hospital
LABELER NAME: Avera McKennan Hospital
DEA SCHEDULE:
ACTIVE STRENGTH: 4(mg/1)
START MARKETING DATE: 2015-04-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69189-0242_9461c993-f972-4bbb-882b-904034f10236
PRODUCT NDC: 69189-0242
APPLICATION NUMBER: NDA022030

Other FESOTERODINE FUMARATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalToviaz
Cardinal HealthToviaz
Pfizer Laboratories Div Pfizer IncToviaz
Physicians Total Care, Inc.Toviaz
U.S. PharmaceuticalsToviaz